Floatz logo

ct103a cells

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Tongji HospitalCell therapyEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Tongji Hospital
Phase 1CCC
Fludarabine
Tongji Hospital
Phase 1CCC
Lcar-Aio T Cells
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1CC
Universal Cd19 Car-Γδt Cell
Tongji Hospital
Phase 1CC
Calculus Bovis Sativus
Tongji Hospital
N/ANR

Same molecule, other indications

ct103a cells is also rated in:

idiopathic inflammatory myopathyDormant
C
Indicative ·
39 / 100
View asset →
chronic inflammatory demyelinating polyradiculoneuropathyDormant
C
Indicative ·
39 / 100
View asset →
autoimmune encephalitisDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →